SCHEMBL6887288

SCHEMBL6887288

CC(CNC(c1cc(F)cc(F)c1)[C@H](N)[C@@H](C)O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.43
AOC3 Q16853 1/20 0.43
GBA1 P04062 1/20 0.41
TAAR1 Q96RJ0 3/20 0.40
SLC6A2 P23975 5/20 0.36
SLC6A4 P31645 5/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2D6 P10635 3/20 0.36
SLC6A3 Q01959 3/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
ANPEP P15144 1/20 0.35
NR1I2 O75469 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2C P18825 1/20 0.35
LMNA P02545 1/20 0.35
HIF1A Q16665 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893793 0.83 CYP3A4 (0.33) SLC6A2SLC6A4CYP3A4CYP2D6SLC6A3
SCHEMBL6895217 0.83 SIGMAR1 (0.40) CYP2D6IDO1TDO2LMNAKDM4E
SCHEMBL6893114 0.81 SIGMAR1 (0.42) SLC6A2SLC6A4SLC6A3ANPEPKDM4E
SCHEMBL6892044 0.80 LMNA (0.38) GBA1CYP2D6IDO1TDO2ADRA2A
SCHEMBL6887515 0.79 CES2 (0.32) SLC6A2SLC6A4CYP3A4CYP2D6SLC6A3
SCHEMBL6887215 0.78 MAOB (0.41) IDO1ANPEP
SCHEMBL6894924 0.77 KDM4E (0.43) AOC3ANPEPADRA2AADRA2CLMNA
SCHEMBL6895263 0.77 KDM4E (0.43) AOC3CYP2D6ANPEPADRA2AADRA2C
SCHEMBL6895046 0.76 IDO1 (0.33) IDO1
SCHEMBL5578711 0.76 BACE1 (0.35) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed